Abeona Therapeutics Inc. Common Stock (ABEO) is a publicly traded Healthcare sector company. As of May 21, 2026, ABEO trades at $5.36 with a market cap of $306.06M and a P/E ratio of -3.42. ABEO moved +4.10% today. Year to date, ABEO is +1.92%; over the trailing twelve months it is -17.13%. Its 52-week range spans $3.93 to $7.54. Analyst consensus is strong buy with an average price target of $20.67. Rallies surfaces ABEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ABEO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $5.36 |
| Market Cap | $306.06M |
| P/E Ratio | -3.42 |
| EPS | $-1.55 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.54 |
| 52-Week Low | $3.93 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-63.73M |
| Gross Margin | 0.00% |
6 analysts cover ABEO: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.67.